Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bach

Showing results (321-330 of 363) with videos related to

Pageof 37
Sort By:
The American Journal of Cardiology|February 3, 2012
Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesionsYogesh Patel, Jeremiah P Depta, Eric Novak, et al.
Annals of Internal Medicine|August 4, 2004
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesRichard G Bach, Christopher P Cannon, William S Weintraub, et al.
Circulation. Cardiovascular Quality and Outcomes|May 22, 2010
Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarctionAdam C Salisbury, Karen P Alexander, Kimberly J Reid, et al.
Circulation|April 23, 2014
Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial"Richard G Bach, Maria Mori Brooks, Manuel Lombardero, et al.
Circulation|September 14, 2011
Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trialSharon Cresci, Jun Wu, Michael A Province, et al.
Journal of the American Heart Association|August 21, 2015
Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary SyndromeShriti Masrani Mehta, Jeremiah P Depta, Eric Novak, et al.
Circulation|August 11, 2020
Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support"Amit P Amin, Sunil V Rao, Richard G Bach, et al.
Circulation|November 19, 2019
The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory SupportAmit P Amin, John A Spertus, Jeptha P Curtis, et al.
The American Journal of Cardiology|May 8, 2012
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry)Ronald P Caputo, Ankush Goel, Michael Pencina, et al.
The American Journal of Cardiology|May 20, 2014
Outcomes of coronary stenoses deferred revascularization for borderline versus nonborderline fractional flow reserve valuesJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
Pageof 37

Showing results (321-330 of 363) with videos related to

Sort By:
Pageof 37
The American Journal of Cardiology|February 3, 2012
Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesionsYogesh Patel, Jeremiah P Depta, Eric Novak, et al.
Annals of Internal Medicine|August 4, 2004
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesRichard G Bach, Christopher P Cannon, William S Weintraub, et al.
Circulation. Cardiovascular Quality and Outcomes|May 22, 2010
Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarctionAdam C Salisbury, Karen P Alexander, Kimberly J Reid, et al.
Circulation|April 23, 2014
Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial"Richard G Bach, Maria Mori Brooks, Manuel Lombardero, et al.
Circulation|September 14, 2011
Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trialSharon Cresci, Jun Wu, Michael A Province, et al.
Journal of the American Heart Association|August 21, 2015
Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary SyndromeShriti Masrani Mehta, Jeremiah P Depta, Eric Novak, et al.
Circulation|August 11, 2020
Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support"Amit P Amin, Sunil V Rao, Richard G Bach, et al.
Circulation|November 19, 2019
The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory SupportAmit P Amin, John A Spertus, Jeptha P Curtis, et al.
The American Journal of Cardiology|May 8, 2012
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry)Ronald P Caputo, Ankush Goel, Michael Pencina, et al.
The American Journal of Cardiology|May 20, 2014
Outcomes of coronary stenoses deferred revascularization for borderline versus nonborderline fractional flow reserve valuesJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
Pageof 37